Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity.
about
Prior exposure to a behaviorally sensitizing regimen of d-methamphetamine does not alter the striatal dopaminergic damage induced by a neurotoxic regimenDoes the concept of "sensitization" provide a plausible mechanism for the putative link between the environment and schizophrenia?Schizophrenia: a tale of two critical periods for prefrontal cortical developmentDopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers.Making Sense of: Sensitization in SchizophreniaApomorphine and the dopamine hypothesis of schizophrenia: a dilemma?Amphetamine-induced Fos is reduced in limbic cortical regions but not in the caudate or accumbens in a genetic model of NMDA receptor hypofunctionDysfunctional GABAergic inhibition in the prefrontal cortex leading to "psychotic" hyperactivationTime flies like an arrow. Fruit flies like crack?Developing treatments for cognitive deficits in schizophrenia: the challenge of translation.Oxytocin in schizophrenia: a review of evidence for its therapeutic effects.Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.Physiogenomic analysis of localized FMRI brain activity in schizophrenia.Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia?Spontaneous low-frequency fluctuations in the BOLD signal in schizophrenic patients: anomalies in the default network.In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders.The extended amygdala and the dopamine system: another piece of the dopamine puzzle.Effect of the glucocorticoid receptor antagonist RU486 on MK-801 induced behavioural sensitisation.Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies.Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium.Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia.Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study.Presynaptic regulation of dopamine transmission in schizophrenia.Signal transduction mechanisms and behavioral sensitization to stimulant drugs: an overview of cAMP and PLA2.Effects of clozapine, haloperidol, and fluoxetine on the reversal of cocaine-induced locomotor sensitization.SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.First-episode mania: a neglected priority for early intervention.Dopamine in the history of the schizophrenic brain: recent contributions of brain-imaging studies.Neonatal disconnection of the rat hippocampus: a neurodevelopmental model of schizophrenia.Behavioral sensitization, alternative splicing, and d3 dopamine receptor-mediated inhibitory function.Using animal models to test a neurodevelopmental hypothesis of schizophreniaRisperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions.Quetiapine versus aripiprazole in the management of schizophrenia.Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders.Abnormal neurotransmitter release underlying behavioral and cognitive disorders: toward concepts of dynamic and function-specific dysregulation.Are anticorrelated networks in the brain relevant to schizophrenia?Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway.A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia.Urbanicity, social adversity and psychosisImaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing.
P2860
Q23912103-317640F2-1740-4881-B6D6-773429F6C529Q24643912-DB362379-7A01-490D-B64F-5F98F304EA7FQ26797157-24C21A76-4F34-42B0-8315-0B58F260E171Q27337060-8C3708B6-727E-43D3-BCCF-6E0B8B1E50E3Q28077939-31DECE29-A2DC-4ACC-AE95-8E99C5346D25Q28366409-466E9C17-C235-4952-B3DC-AE8CFBD6A810Q28590145-35A29C29-E617-49BA-8E3E-682FDFE0B877Q28754545-957E9A54-2087-4168-AD9D-FE8E90C11B14Q30309107-9438CF01-4CD1-44BF-BC58-5F69C827D235Q30396775-D60433A9-C4B5-43DC-B6E6-C588D824323DQ30453929-00FB8B97-7966-4569-8654-C60F95B51C5FQ30489404-0F8E234C-E672-41C2-B9CB-1D97EB417789Q30490136-00BE2006-C8B4-451C-BAD4-63293C547A28Q30491317-872DE697-3FB5-4603-8DE3-7798AA2E6ECFQ31115081-8FDC9CB8-35DD-45FF-8D6B-2AF037F95395Q32115381-165FB3CD-D864-4579-91DB-652DA22E56B0Q33338648-AB0DA9C7-F54B-4B4E-8F25-FCA751FA6C4EQ33590375-7DA2469C-5AA5-47BF-A57F-83C0B86DDFC0Q33833648-3000630B-8633-425B-9E61-DD6C835D2DA9Q33862078-618C0BBE-74F4-49DD-8D68-57E4C67082C8Q33966168-D9A56A04-636F-4721-8EC5-E93AFC707604Q34415874-F7F3F13D-37EB-4A1D-81AD-0250616D06EFQ34415890-DB786690-9068-49CB-9E57-EB432CABCF27Q34420274-6D1D8ED9-BB25-4F78-8283-0F6E58B83C8BQ34476507-A7291FCD-0EB3-4AEB-9712-ED786EF998C7Q34561031-20860451-C567-48AE-8F7B-6A1D40F8EF98Q34619184-5B9BA1FB-3769-4F35-83DD-E5BCEFD1C0A7Q35236303-FE8408D9-BC6A-445D-900F-4D0294D5DB83Q35236537-B28B0B49-4535-4964-868C-68F70AA216DAQ35669960-6597CA75-24F9-4760-B84B-10BA8BD4AE5FQ35712143-622B8538-2B2E-4CEE-BB3D-7FC6BC8B5063Q35742020-1A5E1454-D7EA-405D-BCA3-063E2E37A56DQ35852537-8E61D637-5F27-403A-8421-BE0DBB2F2E2FQ36566937-AD906B50-C020-47AB-AA8E-8B86E095821BQ36681956-42CAB59D-C72F-40AE-A5C7-F917A9AB9562Q36817750-75B43CA9-3E3B-45F5-8822-6531BFBBB57EQ36864001-8A6216E8-6A70-4CBD-B723-9DDA4997A737Q37212798-2EDD4B02-572B-4A29-B786-A81D12E8BDA2Q37236129-76B2E95F-CE41-47D1-AC93-14A615E8BC06Q37320771-546DE92A-C143-4F34-A4D2-2D7F37EE42A2
P2860
Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Neurochemical sensitization in ...... nal regulation and plasticity.
@en
type
label
Neurochemical sensitization in ...... nal regulation and plasticity.
@en
prefLabel
Neurochemical sensitization in ...... nal regulation and plasticity.
@en
P2093
P1476
Neurochemical sensitization in ...... nal regulation and plasticity.
@en
P2093
B B Sheitman
J A Lieberman
P304
P356
10.1016/S0893-133X(97)00045-6
P407
P577
1997-10-01T00:00:00Z
P5875
P6179
1029338416